Marcos Milla, Venture Partner

Professional Overview

Marcos Milla is an accomplished biotechnology executive and venture capitalist with a proven track record of driving innovation and advancing cutting-edge therapeutics. As a Venture Partner at Samsara BioCapital, he leverages his deep scientific expertise and industry experience to identify and support promising early-stage companies in the life sciences sector.

Experience Summary

Current Role

As a Venture Partner at Samsara BioCapital, Marcos plays a key role in the firm's investment strategy, evaluation of potential opportunities, and value creation for portfolio companies. He lends his strategic guidance and technical acumen to guide the development of transformative therapies, contributing to Samsara's mission of advancing life-changing innovations.

Career Progression

Prior to his current role, Marcos served as the Chief Scientific Officer and Senior Vice President of Research at Synthorx Inc., where he led the company's research and development efforts, culminating in its successful acquisition by Sanofi. He also held the position of Vice President of Therapeutics at Adaptive Biotechnologies Corp., where he played a pivotal role in the advancement of the company's innovative immune-profiling platform.

Academic Background

Marcos holds a strong academic foundation, with a degree from Universidad Peruana Cayetano Heredia, a leading institution in Peru. His specialized training and expertise have been instrumental in driving his success in the biotechnology industry.

Areas of Expertise

Marcos is a seasoned biotechnology executive with deep expertise in drug discovery, research and development, and scientific strategy. He possesses a keen understanding of the complexities of the life sciences industry and a proven ability to navigate the regulatory landscape. Additionally, Marcos has demonstrated strong leadership skills, effectively guiding cross-functional teams and fostering collaborative environments.

Professional Impact

Throughout his career, Marcos has made significant contributions to the advancement of novel therapeutic approaches. His work has led to the development of cutting-edge technologies and the successful translation of scientific discoveries into viable commercial products. As a Venture Partner, Marcos continues to leverage his expertise to identify and support promising early-stage companies, driving innovation and creating value for investors and patients alike.

Conclusion

Marcos Milla's extensive experience, scientific acumen, and strategic vision make him a valuable asset in the biotechnology industry. As a Venture Partner at Samsara BioCapital, he is well-positioned to identify and nurture the next generation of life-changing innovations, ultimately contributing to the improvement of human health and well-being.